Direct radioimmunoassay of specific urinary estrogen glucosiduronates in normal men and nonpregnant women.
Direct radioimmunoassay are described for the measurement of each of three specific estrogen glucosiduronates: estrone glucosiduronate, 17 beta-estradiol-17-glucosiduronate and estriol-16 alpha-glucosiduronate in urine. Each assay utilizes a specific antiserum prepared by complexing the carboxylic acid group of the appropriate glucosiduronate to the epsilon-amino group of lysine in bovine serum albumin or bovine thyroglobulin. The antisera showed little or no cross reactivity toward other estrogens that might be present in significant amounts in urine. These antisera were used for the direct assay of the conjugates in urine from normal men and nonpregnant women without prior extraction or chromatography. The values were similar to those obtained after extraction, chromatographic purification on DEAE-Sephadex and subsequent immunoassay; The following mean values +/- SE (microgram/g creatinine) were obtained: estrone glucosiduronate, male 10.1 +/- 0.6, follicular phase female 17.3+/- 1.6, luteal phase female 31.8 +/- 2.5; 17 beta-estradiol-17-glucosiduronate, male 1.7 +/- 0.3, follicular phase female 2.4 +/- 0.1, luteal phase female 4.2 +/- 0.4; estriol-16 alpha-glucosiduronate, male 1.8 +/- 0.2, follicular phase female 4.7 +/- 0.9, luteal phase female 10.0 +/- 1.6.
D000918:Antibody Specificity; D004958:Estradiol / Q000031:analogs & derivatives; D004964:Estriol / Q000031:analogs & derivatives; D004967:Estrogens / Q000276:immunology; D004966:Estrogens, Conjugated (USP) / Q000276:immunology / Q000652:urine*; D004970:Estrone / Q000031:analogs & derivatives; D005260:Female; D005965:Glucuronates / Q000652:urine; D006801:Humans; D008297:Male; D011863:Radioimmunoassay / Q000379:methods
D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D005965:Glucuronates; D004970:Estrone; D004958:Estradiol; D004964:Estriol